SSH - DES MOINES
1. Target Overview & Investment Thesis
SSH - DES MOINES is a 30-bed community hospital in POLK, IA with $12.3M in net patient revenue and a 4.3% operating margin. The hospital serves a payer mix of 66.1% Medicare, 0.0% Medicaid, and 33.9% commercial.
Thesis: Turnaround. Our ML models identify $907K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.3% to 11.7% (+739bps).
| Net Revenue HCRIS | $12.3M |
| Current EBITDA COMPUTED | $525K |
| Operating Margin COMPUTED | 4.3% |
| Occupancy HCRIS | 66.5% |
| Revenue / Bed COMPUTED | $409K |
| Net-to-Gross HCRIS | 14.4% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
IA has 124 Medicare-certified hospitals with a median operating margin of -8.2%. The target's margin of 4.3% places it above the state median. Among 91 size-comparable peers (15-60 beds), the median margin is -8.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (15-60), prioritizing same-state peers. 91 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SSH - DES MOINES (Target) | IA | 30 | $12.3M | 4.3% |
| TRINITY REGIONAL MEDICAL CENTE | IA | 44 | $140.4M | -6.8% |
| PELLA REGIONAL HEALTH CENTER | IA | 25 | $108.8M | -16.6% |
| SPENCER MUNICIPAL HOSPITAL | IA | 49 | $108.7M | -10.3% |
| GREATER REGIONAL MEDICAL CENTE | IA | 25 | $89.4M | -4.4% |
| ST. ANTHONY REGIONAL HOSPITAL | IA | 49 | $84.0M | -21.0% |
| WINNESHIEK MEDICAL CENTER | IA | 25 | $77.6M | -0.1% |
| IOWA SPECIALTY HOSPITAL - CLAR | IA | 25 | $77.3M | 0.2% |
| MAHASKA HEALTH PARTNERSHIP | IA | 25 | $75.6M | -3.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $907K (739bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $258K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $246K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $245K | +199bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $149K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +8bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $525K |
| + RCM Uplift | +$907K |
| Pro Forma EBITDA | $1.4M |
| Current Margin | 4.3% |
| Pro Forma Margin | 11.7% |
| WC Released (1x) | $471K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $808K | $12.5M | 15.51x | 73.0% |
| Base (11x exit) | 10.0x | 11.0x | $808K | $14.0M | 17.38x | 77.0% |
| Bull Case | 9.0x | 11.0x | $727K | $17.3M | 23.79x | 88.5% |
| Bull (12x exit) | 9.0x | 12.0x | $727K | $19.1M | 26.25x | 92.2% |
| Bear Case | 11.0x | 10.0x | $889K | $7.7M | 8.70x | 54.1% |
| Bear (11x exit) | 11.0x | 11.0x | $889K | $8.8M | 9.90x | 58.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Heavy Medicare dependence | Medicare comprises 66.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 91 hospitals with 15-60 beds
- Same-state prioritization (n=92)
- Comp margins: P25=-14.2% / P50=-8.3% / P75=-3.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.